Zobrazeno 1 - 4
of 4
pro vyhledávání: '"C Zuurbier"'
Autor:
P E Nikolaou, N Mylonas, M Makridakis, M Makrecka-Kuka, A Iliou, S Zerikiotis, P Efentakis, N Kostomitsopoulos, R Vilskersts, C Zuurbier, A Latosinska, A Vlahou, G Dimitriadis, E K Iliodromitis, I Andreadou
Publikováno v:
European Heart Journal. 43
Background Empagliflozin (EMPA), Dapagliflozin (DAPA) and Ertugliflozin (ERTU) are selective sodium glucose co-transporter 2 inhibitors (SGLT2i) acting against type 2 diabetes mellitus. Purpose Due to differences in clinical trial outcomes, we aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9aeb67decfb30e45e5c2d70784deeb4
https://doi.org/10.1093/eurheartj/ehac544.2905
https://doi.org/10.1093/eurheartj/ehac544.2905
Glucose-Insulin Therapy, Plasma Substrate Levels and Cardiac Recovery After Cardiac Ischemic Events.
Autor:
C. Zuurbier, H. Van Wezel
Publikováno v:
Cardiovascular Drugs & Therapy; Apr2008, Vol. 22 Issue 2, p125-131, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zuurbier C; Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands., Greving JP; University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands., Rinkel G; Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands., Ruigrok YM; Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
European stroke journal [Eur Stroke J] 2020 Mar; Vol. 5 (1), pp. 73-77. Date of Electronic Publication: 2019 Aug 19.